.svg){kind=small}
Jun-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Kind Medicine has shown notable performance variations across different states and categories. In California, the brand has made significant strides within the Tincture & Sublingual category. Specifically, while Kind Medicine was ranked 25th in March 2024, it did not appear in the top 30 rankings for April and May, indicating a period of underperformance. However, by June 2024, the brand had a remarkable comeback, climbing to the 17th position. This upward movement is indicative of a strong recovery and suggests that the brand's strategies in California are beginning to pay off.
While the resurgence in California is promising, the absence of rankings in April and May could be seen as a cause for concern. The period of non-ranking months might reflect challenges that the brand faced, such as increased competition or market saturation. Nevertheless, the brand's ability to bounce back and achieve a higher rank in June demonstrates resilience and effective market adaptation. Observing these fluctuations can provide deeper insights into the brand's performance trends and market dynamics, offering valuable lessons for future strategic planning.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in California, Kind Medicine has experienced notable fluctuations in its market rank and sales. After being ranked 25th in March 2024, Kind Medicine did not appear in the top 20 for April and May, indicating a significant drop in visibility and market presence. However, by June 2024, Kind Medicine rebounded to 17th place, showing a positive trend in its market performance. In contrast, competitors like Breez maintained a consistent 13th rank from March to June 2024, while Cosmic View experienced a decline from 16th in March to 19th in June. Dr. May and Moods Spray also showed varying levels of stability and decline. These dynamics suggest that while Kind Medicine faces stiff competition, its ability to regain rank indicates potential for growth and increased market share if it can sustain its upward trajectory.
Notable Products
In June 2024, the top-performing product for Kind Medicine was Sativa Tincture (800mg THC, 30ml), which saw a significant increase in sales to $219. Indica Tincture (800mg THC, 30ml) came in second, maintaining a strong presence but dropping from its consistent first-place ranking in April and May. The CBD:THC 20:1 Tincture (450mg CBD, 22.4mg THC 30ml) secured the third spot, making a notable entry into the rankings. CBD/THC 25:1 Pet Tincture (500mg CBD, 20mg THC, 30ml) remained steady in fourth place, similar to its ranking in May. Sativa Capsules 10-Pack (300mg) rounded out the top five, showing a slight decline from its second-place position in May.
Top Selling Cannabis Brands
